| ￥1200 | |
| A04694-50 | |
|
|
|
|
|
|
|
|
|
| Specificity | This product is specific to UBE2N |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human UBE2N |
| Species Reactivity | Human; Mouse; Rat |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||
|
|||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Western blot analysis of Ube2N / Ubc13 expression in Daudi cell lysate. »
| Target Background | The UBE2V1-UBE2N and UBE2V2-UBE2N heterodimers catalyze the synthesis of non-canonical 'Lys-63'-linked polyubiquitin chains. This type of polyubiquitination does not lead to protein degradation by the proteasome. Mediates transcriptional activation of target genes. Plays a role in the control of progress through the cell cycle and differentiation. |
| Synonyms | BLU; HEL-S-71; Ubc13; UbCH ben; UbcH13; UBCHBEN; Ube2n; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
